Based on histological and molecular evidence, BRCA can be clinically categorized into three subtypes: hormone receptor‐positive breast cancer (ER or PR positive), HER2 (ERBB2 positive) breast cancer, and triple‐negative breast cancer (TNBC) (ER‐/PR‐/HER2‐).3 This evidence concerns the gene ERBB2 and breast carcinoma.